Latest News
-
Kolling Institute Year in Review 2025
Posted on:
Our Year in Review highlights the significant impact, collaboration and momentum across the Kolling Institute, and comes as we mark an important milestone with the launch of our 2026–2030 Research Strategy. Kolling researchers achieved great success in 2025, expanding the scale, reach and influence of their research across their discovery, translational and clinical disciplines. These achievements…
-
Researchers unveil the key to ageing well
Posted on:
Clinical and research experts across the Kolling Institute passionately discussed the potential of their research to provide crucial new knowledge and effective treatments to support healthy ageing during a recent event. Hosted by the NORTH Foundation, more than 150 people came together for the Living Longer, Living Better showcase, including donors, supporters and health professionals.…
-
Landmark gift to drive new knowledge and reduce pancreatic cancer toll
Posted on:
Internationally-recognised investigator Professor Marina Pajic has begun her new role as the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research determined to accelerate research into one of Australia’s most challenging cancers. Based at the Kolling Institute, Professor Pajic will be working within the University of Sydney. Her position follows a remarkable $11 million…
Primary Research Area/s: Research Excellence -
New strategy to escalate research impact and deliver world leading care
Posted on:
More than 150 people came together for the launch of the Kolling Institute’s Research Strategy 2026-2030, a roadmap to strengthen research expertise and expand access to high-value care. Developed through extensive consultation with researchers, clinicians, consumers, and partners, the strategy provides a framework to guide future growth, innovation and impact. Academic Director Professor James Elliott…
Primary Research Area/s: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence -
Internationally-recognised researchers join the Kolling
Posted on:
Our cancer and musculoskeletal expertise has been strengthened with the appointment of two senior researchers and their teams to the Kolling Institute. Professor Marina Pajic has been appointed the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research following a remarkable $11 million gift. It is the largest individual philanthropic gift to pancreatic cancer research in Australia.…
-
New funding to shift fragmented osteoarthritis care towards prevention, earlier prediction and better outcomes
Posted on:
The unique expertise of our osteoarthritis researchers at the Kolling Institute has been recognised, with world-leading clinician researcher Professor David Hunter receiving a remarkable $3 million NHMRC Leadership Investigator Grant. These grants are the NHMRC’s flagship funding scheme, offering valuable research support and flexibility. They are highly competitive, with just 234 of the nearly 1,900…
Primary Research Area/s: Research Excellence -
Kolling Showcase – Living Longer, Living Better
Posted on:
Join us for Living Longer, Living Better, the inaugural event in the new Kolling Showcase Series. Bringing together leading researchers, supporters and community members, this special afternoon will explore the work transforming the future of ageing. Discover how this research is helping older Australians live longer, healthier and more independent lives. You’ll also learn how…
-
Physiotherapist’s quest to understand muscle fat
Posted on:
Kolling researcher and physiotherapist Brian Kim has spent most of his career in orthopaedic clinics, helping patients recover from or prepare for surgery. Over time, he noticed something unusual in MRI scans, some muscles showed streaks or “marbling” of fat. While tears and inflammation were easy to spot, this fatty appearance was harder to interpret. …
Primary Research Area/s: New Treatment -
Historic research achievement
Posted on:
Leading Royal North Shore Hospital clinician researcher Associate Professor Brendon Neuen has had three major studies published in the world’s three most prestigious medical journals on the same day – in a rare achievement in clinical research. A/Professor Neuen led the research showing that a new medication protects the kidneys, reduces heart risks, and improves…
Primary Research Area/s: Cardiovascular and Renal Research -
Innovative cancer clinical trials unit unveiled
Posted on:
Researchers from the Kolling Institute will help progress the latest cancer treatments following the official opening of an early phase clinical trials unit at Royal North Shore Hospital. The early phase unit of the NORTH STAR Van Norton Poche Cancer Trials Centre is a dedicated facility to meet the needs of patients and their carers,…
Primary Research Area/s: Research Excellence
